These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 9029734)
1. Structure-function relationships of 3 beta-hydroxysteroid dehydrogenase: contribution made by the molecular genetics of 3 beta-hydroxysteroid dehydrogenase deficiency. Morel Y; Mébarki F; Rhéaume E; Sanchez R; Forest MG; Simard J Steroids; 1997 Jan; 62(1):176-84. PubMed ID: 9029734 [TBL] [Abstract][Full Text] [Related]
2. Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues. Labrie F; Simard J; Luu-The V; Bélanger A; Pelletier G J Steroid Biochem Mol Biol; 1992 Dec; 43(8):805-26. PubMed ID: 22217825 [TBL] [Abstract][Full Text] [Related]
3. Structure-function relationships and molecular genetics of the 3 beta-hydroxysteroid dehydrogenase gene family. Simard J; Sanchez R; Durocher F; Rhéaume E; Turgeon C; Labrie Y; Luu-The V; Mebarki F; Morel Y; de Launoit Y J Steroid Biochem Mol Biol; 1995 Dec; 55(5-6):489-505. PubMed ID: 8547174 [TBL] [Abstract][Full Text] [Related]
4. Molecular basis of human 3 beta-hydroxysteroid dehydrogenase deficiency. Simard J; Rheaume E; Mebarki F; Sanchez R; New MI; Morel Y; Labrie F J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):127-38. PubMed ID: 7626445 [TBL] [Abstract][Full Text] [Related]
5. Nonsalt-losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene. Mébarki F; Sanchez R; Rhéaume E; Laflamme N; Simard J; Forest MG; Bey-Omar F; David M; Labrie F; Morel Y J Clin Endocrinol Metab; 1995 Jul; 80(7):2127-34. PubMed ID: 7608265 [TBL] [Abstract][Full Text] [Related]
6. Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase deficiency. Simard J; Moisan AM; Morel Y Semin Reprod Med; 2002 Aug; 20(3):255-76. PubMed ID: 12428206 [TBL] [Abstract][Full Text] [Related]
7. Molecular basis of congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency. Simard J; Rhéaume E; Sanchez R; Laflamme N; de Launoit Y; Luu-The V; van Seters AP; Gordon RD; Bettendorf M; Heinrich U Mol Endocrinol; 1993 May; 7(5):716-28. PubMed ID: 8316254 [TBL] [Abstract][Full Text] [Related]
8. Mutation in the human gene for 3 beta-hydroxysteroid dehydrogenase type II leading to male pseudohermaphroditism without salt loss. Russell AJ; Wallace AM; Forest MG; Donaldson MD; Edwards CR; Sutcliffe RG J Mol Endocrinol; 1994 Apr; 12(2):225-37. PubMed ID: 8060486 [TBL] [Abstract][Full Text] [Related]
9. Detection and functional characterization of the novel missense mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene of a female patient with nonsalt-losing 3 beta HSD deficiency. Sanchez R; Rhéaume E; Laflamme N; Rosenfield RL; Labrie F; Simard J J Clin Endocrinol Metab; 1994 Mar; 78(3):561-7. PubMed ID: 8126127 [TBL] [Abstract][Full Text] [Related]
10. New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes. Moisan AM; Ricketts ML; Tardy V; Desrochers M; Mébarki F; Chaussain JL; Cabrol S; Raux-Demay MC; Forest MG; Sippell WG; Peter M; Morel Y; Simard J J Clin Endocrinol Metab; 1999 Dec; 84(12):4410-25. PubMed ID: 10599696 [TBL] [Abstract][Full Text] [Related]
11. A novel nonstop mutation in the stop codon and a novel missense mutation in the type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing, respectively, nonclassic and classic 3beta-HSD deficiency congenital adrenal hyperplasia. Pang S; Wang W; Rich B; David R; Chang YT; Carbunaru G; Myers SE; Howie AF; Smillie KJ; Mason JI J Clin Endocrinol Metab; 2002 Jun; 87(6):2556-63. PubMed ID: 12050213 [TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of the G15D mutation found in a male patient with 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) deficiency: alteration of the putative NAD-binding domain of type II 3 beta-HSD. Rhéaume E; Sanchez R; Mébarki F; Gagnon E; Carel JC; Chaussain JL; Morel Y; Labrie F; Simard J Biochemistry; 1995 Mar; 34(9):2893-900. PubMed ID: 7893703 [TBL] [Abstract][Full Text] [Related]
13. A novel mouse kidney 3 beta-hydroxysteroid dehydrogenase complementary DNA encodes a 3-ketosteroid reductase instead of a 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase. Clarke TR; Bain PA; Greco TL; Payne AH Mol Endocrinol; 1993 Dec; 7(12):1569-78. PubMed ID: 8145763 [TBL] [Abstract][Full Text] [Related]
14. Functional characterization of the novel L108W and P186L mutations detected in the type II 3 beta-hydroxysteroid dehydrogenase gene of a male pseudohermaphrodite with congenital adrenal hyperplasia. Sanchez R; Mébarki F; Rhéaume E; Laflamme N; Forest MG; Bey-Omard F; David M; Morel Y; Labrie F; Simard J Hum Mol Genet; 1994 Sep; 3(9):1639-45. PubMed ID: 7833923 [TBL] [Abstract][Full Text] [Related]
15. The murine 3 beta-hydroxysteroid dehydrogenase multigene family: structure, function and tissue-specific expression. Payne AH; Clarke TR; Bain PA J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):111-8. PubMed ID: 7626443 [TBL] [Abstract][Full Text] [Related]
16. A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia. Zhang L; Sakkal-Alkaddour H; Chang YT; Yang X; Pang S J Clin Endocrinol Metab; 1996 Jan; 81(1):291-5. PubMed ID: 8550766 [TBL] [Abstract][Full Text] [Related]